Clostridial agents cannot be eradicated because they are universally present in soil and the intestinal tract of cattle. They produce potent toxins that can result in death of otherwise healthy animals, often with great speed.
Use in healthy cattle against blackleg caused by Clostridium chauvoei, malignant edema-Cl. septicum, black disease-Cl. novyi, gas-gangrene-Cl. sordellii, and enterotoxemia and enteritis caused by Cl. perfringens types B,C, & D.
Clostridial agents cannot be eradicated because they are universally present in soil and the intestinal tract of cattle. They produce potent toxins that can result in death of otherwise healthy animals, often with great speed.
Use in healthy cattle against blackleg caused by Clostridium chauvoei, malignant edema-Cl. septicum, black disease-Cl. novyi, gas-gangrene-Cl. sordellii, and enterotoxemia and enteritis caused by Cl. perfringens types B,C, & D.
For the immunization of healty cattle and swine against Leptospirosis caused by Leptospira Canicola, Grippotyphosa, Hardjo, Icterohaemorrhagiae and Pomona bacterin.
Dosage: 2ml IM or SC in healthy cattle or swine; second dose 2-4 wks. later for swine. Revaccinate annually for both.
For the immunization of healty cattle and swine against Leptospirosis caused by Leptospira Canicola, Grippotyphosa, Hardjo, Icterohaemorrhagiae and Pomona bacterin.
Dosage: 2ml IM or SC in healthy cattle or swine; second dose 2-4 wks. later for swine. Revaccinate annually for both.
Vaccination of healthy cattle and calves as an aid in preventing disease caused by Haemophilus somnus (a major contributor to respiratory disease and cause of thrombotic meningoencephalitis (TEME) and reproductive tract infection)
Contains three inactivated isolates of H. somnusfrom respiratory, reproductive, and nervous tissue.
Use in healthy cattle against blackleg caused by Clostridium chauvoei, malignant edema-Cl. septicum, black disease-Cl. novyi, gas-gangrene-Cl. sordellii, and enterotoxemia and enteritis -Cl. perfringens types B, C, and D.
Use as an aid in preventing bacillary hemoglobinuria caused by Cl. haemolyticum.
Use in healthy cattle against blackleg caused by Clostridium chauvoei, malignant edema-Cl. septicum, black disease-Cl. novyi, gas-gangrene-Cl. sordellii, and enterotoxemia and enteritis -Cl. perfringens types B, C, and D.
Use as an aid in preventing bacillary hemoglobinuria caused by Cl. haemolyticum.
3-Way live virus for the vaccination of healthy cattle against IBR, BVD, and Type I and II (BVD).
Inject 2 mL sub-Q or IM. Annual revaccination is recommended. If vaccinated prior to weaning, repeat 30 days after weaning when the possible influence of maternal antibodies is decreased.
Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is USDA-approved for the reduction of clinical signs and mortality associated with K99 E. coli diarrhea in neonatal calves.
Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is CFIA-approved for the reduction of clinical signs and mortality associated with K99 E. coli diarrhea in neonatal calves.
Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is CFIA-approved for the reduction of clinical signs and mortality associated with K99 E. coli diarrhea in neonatal calves.
Recommended for the prevention of urinary shedding of L. borgpetersenii serovar hardjo (type hardjo-bovis). Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure. For vaccination of healthy, susceptible cattle as an aid in the reduction of infertility, delayed conception, or abortion caused by Campylobacter fetus var. venerealis and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona.
Recommended for the prevention of urinary shedding of L. borgpetersenii serovar hardjo (type hardjo-bovis). Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure. For vaccination of healthy, susceptible cattle as an aid in the reduction of infertility, delayed conception, or abortion caused by Campylobacter fetus var. venerealis and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona.
For vaccination of healthy, suscepible cows and replacement heifers prior to breeding to prevent persistently infected calves due to BVD Types 1 and 2.
Four non-cytopathic BVD challenge viruses were used in five different challenge studies to determine the efficacy of this product in preventing persistently infected calves due to BVD Types 1 and 2.
For vaccination of healthy, suscepible cows and replacement heifers prior to breeding to prevent persistently infected calves due to BVD Types 1 and 2.
Four non-cytopathic BVD challenge viruses were used in five different challenge studies to determine the efficacy of this product in preventing persistently infected calves due to BVD Types 1 and 2.
POLYFLEX (ampicillin for injectable suspension, veterinary) is a broad-spectrum penicillin which has bactericidal activity against a wide range of common gram-positive and gram-negative bacteria.
The antimicrobial action of ampicillin is bactericidal, and only a small percentage of the antibiotic is serum-bound.
Indicated for vaccination of healthy cattle as an aid in the prevention of disease caused by bovine rhinotracheitis and bovine virus diarrhea (Types I and II).
Recommended for the vaccination of healthy, susceptible sheep and cattle against enterotoxemia caused by the toxins of Clostridium perfringens types C & D.
For Cattle inject 5 mL subQ. Repeat in 21 to 28 days and annually. Sheep use the same schedule but with 2ml dosage.
For vaccination of healthy, susceptible sheep, goats, and cattle against enterotoxemia and tetanus caused by the toxins of Clostridium perfringens Types C and D and Cl tetani.
Although Cl perfringens Type B is not a significant problem in the USA, immunity may be provided against the beta and epsilon toxins elaborated by Cl perfringens Type B.
For the vaccination of healthy susceptible cattle against Haemophilus somnus, Pasteurella haemolytica and Pasteurella multocida.
Inject 2 mL IM in healthy cattle of any age. Repeat in 21 days and once annually. Calves vaccinated before six months of age should be revaccinated after 6 months of age.
For the vaccination of healthy susceptible cattle against Haemophilus somnus, Pasteurella haemolytica and Pasteurella multocida.
Inject 2 mL IM in healthy cattle of any age. Repeat in 21 days and once annually. Calves vaccinated before six months of age should be revaccinated after 6 months of age.
An economical, convenient way to booster Alpha-7/MB or add M bovis pinkeye to any cattle management program.
Prevention and control of infectious bovine keratoconjunctivitis pinkeye in cattle caused by M bovis. Vaccine expresses the I and Q phase pilus antigens.
An economical, convenient way to booster Alpha-7/MB or add M bovis pinkeye to any cattle management program.
Prevention and control of infectious bovine keratoconjunctivitis pinkeye in cattle caused by M bovis. Vaccine expresses the I and Q phase pilus antigens.
For vaccination of healthy, susceptible cattle against IBR, BVD Types 1 & 2, PI3, BRSV, H somnus.
2 mL dose Sub-Q in front of the shoulder and midway of the neck away from the suprascapular lymph node. Repeat BRSV and H somnus fractions in 14 to 28 days. A 2 mL booster recommended annually. Calves vaccinated before 6 mo of age-revaccinated at 6mo.
For vaccination of healthy, susceptible sheep, goats, and cattle against enterotoxemia and tetanus caused by the toxins of Clostridium perfringens Types C and D and Cl tetani.
Although Cl perfringens Type B is not a significant problem in the USA, immunity may be provided against the beta and epsilon toxins elaborated by Cl perfringens Type B.
For vaccination of healthy, susceptible cattle against IBR, BVD Types 1 & 2, PI3, BRSV, H somnus.
2 mL dose Sub-Q in front of the shoulder and midway of the neck away from the suprascapular lymph node. Repeat BRSV and H somnus fractions in 14 to 28 days. A 2 mL booster recommended annually. Calves vaccinated before 6 mo of age-revaccinated at 6mo.
Modified live virus for the vaccination of healthy cattle 1 week of age or older as an aid in the prevention of disease caused by IBR, BRSV and PI3. For intranasal use only. Designed with an IBR that is not temperature sensitive, so the vaccine will replicate and protect in a moderate to high temperature environment. Demonstrated a duration of immunity of 6-1/2 months for IBR, 11 weeks for BRSV and 3 months for PI3
Increxxa contains tulathromycin, the same macrolide antibiotic veterinarians and the cattle industry have depended on to control and treat bovine respiratory disease (BRD) in cattle for more than 15 years. It's a go-to antibiotic for beef and dairy producers because of its one-time use extended duration of action, ease of administration and broad-spectrum control
Nuplura PH provides single dose protection against pasteurella pneumonia (shipping fever) caused by Mannheimia haemolytica in cattle 3 months of age and older.
A single dose demonstrated protective immunity as early as 10 days after administration.
Nuplura PH provides single dose protection against pasteurella pneumonia (shipping fever) caused by Mannheimia haemolytica in cattle 3 months of age and older.
A single dose demonstrated protective immunity as early as 10 days after administration.
For healthy cattle 6 months of age or older as an aid in foot rot symptoms and the number and size of liver abscesses caused by Fusobacterium necrophorum.
Administer 2ml SC in the neck. For footrot revaccinate in 3 wks; for liver abscesses revaccinate in 60 days. Revaccinate annually or in case of predicted exposure.
For healthy cattle 6 months of age or older as an aid in foot rot symptoms and the number and size of liver abscesses caused by Fusobacterium necrophorum.
Administer 2ml SC in the neck. For footrot revaccinate in 3 wks; for liver abscesses revaccinate in 60 days. Revaccinate annually or in case of predicted exposure.
Scour Bos 9 at dry-off begins a lifetime of production.
Vaccinating a dry cow today with Scour Bos 9 ensure tomorrow's calf will consume colostrum that carries powerful antibodies enabling her to grow up to be the healthiest, strongest producer she can be.
Scour Bos 9 at dry-off begins a lifetime of production.
Vaccinating a dry cow today with Scour Bos 9 ensure tomorrow's calf will consume colostrum that carries powerful antibodies enabling her to grow up to be the healthiest, strongest producer she can be.
For vaccination of healthy dairy or beef cattle three months of age or older as an aid in the prevention of pneumonic pasteurellosis by stimulating immunity to Mannheimia (P.) haemolytica.
A single dose only will confer active immunity, however a booster dose is recommended whenever subsequent stress is likely.
For healthy dairy or beef cattle 7 months or older as an aid to prevent pneumonic pasteurellosis by stimulating immunity to Mannheimia P. haemolytica and Pasteurella multocida.
Vaccinate a minimum of 14 days prior to shipping or exposure to stress.
For vaccination of healthy dairy or beef cattle three months of age or older as an aid in the prevention of pneumonic pasteurellosis by stimulating immunity to Mannheimia (P.) haemolytica.
A single dose only will confer active immunity, however a booster dose is recommended whenever subsequent stress is likely.
For healthy dairy or beef cattle 7 months or older as an aid to prevent pneumonic pasteurellosis by stimulating immunity to Mannheimia P. haemolytica and Pasteurella multocida.
Vaccinate a minimum of 14 days prior to shipping or exposure to stress.
Modified-live vaccine for IBR, Type I & II BVD, BRSV and PI3, Aids in the prevention of presistant BVD Type I and II infection of the fetal calf when given SubQ to cow or heifer 30-60 days pre-breeding.
IM or subQ single-dose administration; Do not use in pregnant cows or in calves nursing pregnant cows.
Modified-live vaccine for IBR, Type I & II BVD, BRSV and PI3, Aids in the prevention of presistant BVD Type I and II infection of the fetal calf when given SubQ to cow or heifer 30-60 days pre-breeding.
IM or subQ single-dose administration; Do not use in pregnant cows or in calves nursing pregnant cows.
IBR, BVD Types I and II, PI3, BRSV and 5 strains of Lepto.
Give 2 ml SQ. Safe for pregnant cows, or calves nursing pregnant cows, provided they were vaccinated pre-breeding, according to label directions, with Pyramid 5 or Pyramid 10.